News
The US Food and Drug Administration is starting to publish letters the agency sent to pharmaceutical companies when their ...
The agency disclosed a tranche of more than 200 complete response letters from the past five years, but only those involving ...
The trove of more than 200 letters is part of a pledge of transparency from the agency, with the intention to increase public ...
The FDA has released an "initial batch" of 200 complete response letters (CRLs) in efforts to boost transparency. | The FDA has released an "initial batch" of 200 complete response letters (CRLs) in ...
The U.S. Food and Drug Administration released more than 200 of its so-called complete response letters from its archive on ...
The FDA published more than 200 letters that it sent to companies when it rejected their medicines, but the letters came with a caveat.
The FDA on Thursday said it published more than 200 decision letters, known as complete response letters, that it issued in response to applications for approval of drugs or biological products ...
The U.S. FDA publishes over 200 complete response letters to enhance transparency within the agency. Read more here.
The U.S. Food and Drug Administration on Thursday published more than 200 of its so-called complete response letters to drugmakers, a significant move to increase transparency of the agency's work.
Moderna (MRNA) stock rises as the company's Spikevax COVID-19 vaccine gets FDA approval for kids 6 months-11 years at higher ...
Spikevax is now approved for all adults aged 65 years and older, and individuals aged 6 months through 64 years at increased risk for COVID-19 disease CAMBRIDGE, MA / ACCESS Newswire / July 10, 2025 / ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results